What is The Cancer Code about?

The Cancer Code is Jason Fung's case that oncology's dominant paradigm — cancer as a genetic disease driven by somatic mutations — is incomplete and has contributed to fifty years of largely stagnant survival rates for most cancers. Fung, a Toronto nephrologist known for his work on insulin resistance and fasting, argues that viewing cancer primarily as a metabolic disease rather than a genetic one opens treatment approaches that mainstream oncology has systematically underexplored.

Fung traces the history of cancer research in three paradigms. The first, from Virchow in the nineteenth century, saw cancer as a proliferation disease. The second, which dominated the late twentieth century, identified cancer as primarily a genetic disease caused by mutations in oncogenes and tumor suppressor genes. The third, which Fung advocates, integrates the genetic view with metabolic theory: cancer cells typically rely on aerobic glycolysis (the Warburg effect) for energy even when oxygen is available, and this metabolic signature is both a cause and a consequence of the cancerous state.

The practical section of the book examines what the metabolic view implies for treatment and prevention. Fung argues that dietary interventions that reduce insulin and glucose — particularly low-carbohydrate diets and fasting — may starve cancer cells that depend on glucose while being well-tolerated by healthy cells. He reviews the emerging research on fasting in conjunction with chemotherapy, which suggests that short fasting windows before chemo both protect healthy cells and sensitize cancer cells. He is careful to note that this research is early-stage and should not lead patients to abandon proven treatments.

Fung writes accessibly and his historical framing is genuinely illuminating. The book's main limitation is that it presents an ongoing scientific debate as more settled than it is. The metabolic theory of cancer is a legitimate and growing research area, but it remains contested, and the clinical evidence for dietary interventions in human cancer is thinner than the molecular biology alone might suggest. Readers who want to understand a credible alternative to the pure genetic model will find it clearly explained; those looking for a proven alternative treatment protocol will be ahead of the evidence.